文献速递营养与食品安全传染病防控与疫情报告

口服活二价沙门菌疫苗可减少多重耐药肠道沙门菌血清型I 4,[5],12:i:-的临床疾病、定植与粪便排菌

Oral live bivalent Salmonella vaccine reduces clinical disease, colonization and fecal shedding of multidrug resistant Salmonella enterica serovar I 4,[5],12:i:
PubMed 文献 · Vaccine · 2025-07-26

研究评估含减毒活肠道沙门菌血清型Typhimurium与Choleraesuis的商业疫苗在攻毒猪中的效果。单剂口服接种猪较未接种猪攻毒后腹泻与体温显著降低(每组n=20),攻毒后14天内粪便排菌与肠道组织定植显著减少(定植最多降低2.3 log),定植猪数显著减少,增重显著更高。

要点

  • 单剂口服接种猪攻毒后腹泻与体温显著低于未接种猪(每组n=20)。
  • 攻毒后14天内接种猪粪便排菌与肠道组织定植显著减少,定植最多降低2.3 log。
  • 接种猪定植数量显著减少,攻毒后增重显著高于未接种猪。

核心结论

  • 单剂口服接种该商业减毒活二价疫苗可显著减少多重耐药沙门菌I 4,[5],12:i:-攻毒后的临床疾病、粪便排菌与组织定植,作者认为该疫苗是改善动物健康与食品安全的有效 harvest 前工具。

研究设计与样本

  • 研究评估含减毒活肠道沙门菌血清型Typhimurium与Choleraesuis的商业疫苗在攻毒猪中的效果,疫苗组与未接种组每组n=20。

主要发现

  • 单剂口服接种猪攻毒后腹泻与体温较未接种猪显著降低(每组n=20)。
  • 攻毒后14天内接种猪粪便排菌与肠道组织定植较未接种猪显著减少,定植最多降低2.3 log。
  • 接种猪定植数量较未接种猪显著减少,攻毒后增重显著高于未接种猪。

关键数值与推荐

  • 多重耐药定义为对≥3类抗菌药物耐药。
  • 攻毒后14天内接种猪肠道组织定植最多降低2.3 log。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Salmonella enterica serovar I 4,[5],12:i:- is currently the most common serovar identified in U.S. swine clinical cases and is prevalent worldwide. This serovar also ranks among the leading causes of human foodborne salmonellosis and is the most frequently identified multidrug-resistant (MDR; resistance to ≥3 antimicrobial classes) Salmonella serovar in the U.S. Given its importance to both swine health and food safety, the current study evaluated the efficacy of a commercial vaccine containing live attenuated Salmonella enterica serovars Typhimurium and Choleraesuis in pigs challenged with MDR Salmonella I 4,[5],12:i:-. Pigs vaccinated with a single oral dose exhibited significantly reduced diarrhea and lower body temperatures following challenge compared to non-vaccinated pigs (n = 20/group). During the 14-days post-challenge, vaccinated pigs also demonstrated significantly reduced fecal shedding and up to a 2.3-log reduction in intestinal tissue colonization, as well as a significant reduction in the number of pigs colonized, compared to non-vaccinated pigs. Furthermore, weight gain was significantly higher in vaccinated pigs compared to non-vaccinated pigs after challenge. Collectively, these results demonstrate that vaccination significantly reduces clinical disease, fecal shedding, and tissue colonization following challenge with MDR Salmonella I 4,[5],12:i:-, revealing the vaccine to be an effective pre-harvest tool to improve both animal health and food safety.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Leite FL, Arruda P, Ford B, et al. Oral live bivalent Salmonella vaccine reduces clinical disease, colonization and fecal shedding of multidrug resistant Salmonella enterica serovar I 4,[5],12:i: Vaccine. 2025. PMID: 40716147. doi:10.1016/j.vaccine.2025.127540

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。